-
1
-
-
0021946215
-
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
-
Karmali MA, Petric M, Lim C, Fleming DC, Arthus GS, Lior H,. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 1985; 151: 775-782.
-
(1985)
J. Infect. Dis.
, vol.151
, pp. 775-782
-
-
Karmali, M.A.1
Petric, M.2
Lim, C.3
Fleming, D.C.4
Arthus, G.S.5
Lior, H.6
-
2
-
-
79954441390
-
Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy
-
Keir L, Coward RJ,. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr. Nephrol. 2011; 26: 523-533.
-
(2011)
Pediatr. Nephrol.
, vol.26
, pp. 523-533
-
-
Keir, L.1
Coward, R.J.2
-
3
-
-
77957588040
-
Pathophysiology of typical hemolytic uremic syndrome
-
Karpman D, Sartz L, Johnson S,. Pathophysiology of typical hemolytic uremic syndrome. Semin. Thromb. Hemost. 2010; 36: 575-585.
-
(2010)
Semin. Thromb. Hemost.
, vol.36
, pp. 575-585
-
-
Karpman, D.1
Sartz, L.2
Johnson, S.3
-
4
-
-
51549116628
-
Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
-
Scheiring J, Andreoli SP, Zimmerhackl LB,. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr. Nephrol. 2008; 23: 1749-1760.
-
(2008)
Pediatr. Nephrol.
, vol.23
, pp. 1749-1760
-
-
Scheiring, J.1
Andreoli, S.P.2
Zimmerhackl, L.B.3
-
5
-
-
84869239340
-
Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome
-
Ohara S, Kawasaki Y, Abe Y, et al. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome. Am. J. Nephrol. 2013; 36: 516-523.
-
(2013)
Am. J. Nephrol.
, vol.36
, pp. 516-523
-
-
Ohara, S.1
Kawasaki, Y.2
Abe, Y.3
-
6
-
-
50249083363
-
Risk factors for developing severe clinical course in HUS patients: A national survey in Japan
-
Members of the Japanese Society for Pediatric Nephrology.
-
Kamioka I, Yoshiya K, Satomura K, et al. Members of the Japanese Society for Pediatric Nephrology. Risk factors for developing severe clinical course in HUS patients: A national survey in Japan. Pediatr. Int. 2008; 50: 441-446.
-
(2008)
Pediatr. Int.
, vol.50
, pp. 441-446
-
-
Kamioka, I.1
Yoshiya, K.2
Satomura, K.3
-
7
-
-
63549147220
-
Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli 157
-
Yamamoto T, Satomura K, Okada S, Ozono K,. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli 157. Pediatr. Int. 2009; 51: 216-219.
-
(2009)
Pediatr. Int.
, vol.51
, pp. 216-219
-
-
Yamamoto, T.1
Satomura, K.2
Okada, S.3
Ozono, K.4
-
8
-
-
34147140549
-
Prognosis and pathological characteristic of five children with non-Shiga toxin-mediated hemolytic uremic syndrome
-
Kamioka I, Nozu K, Fujita T, et al. Prognosis and pathological characteristic of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr. Int. 2007; 48: 196-201.
-
(2007)
Pediatr. Int.
, vol.48
, pp. 196-201
-
-
Kamioka, I.1
Nozu, K.2
Fujita, T.3
-
9
-
-
20144386770
-
Childhood hemolytic uremic syndrome, United Kingdom and Ireland
-
Lynn RM, O'Brien SJ, Taylor CM, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg. Infect. Dis. 2005; 11: 590-596.
-
(2005)
Emerg. Infect. Dis.
, vol.11
, pp. 590-596
-
-
Lynn, R.M.1
O'Brien, S.J.2
Taylor, C.M.3
-
10
-
-
0037103517
-
Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the haemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study
-
Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB,. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the haemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study. J. Infect. Dis. 2002; 186: 493-500.
-
(2002)
J. Infect. Dis.
, vol.186
, pp. 493-500
-
-
Gerber, A.1
Karch, H.2
Allerberger, F.3
Verweyen, H.M.4
Zimmerhackl, L.B.5
-
11
-
-
50949103794
-
Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin producing Escherichia coli infections in France, 1996-2006
-
Espie E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin producing Escherichia coli infections in France, 1996-2006. Pediatr. Infect. Dis. J. 2008; 27: 595-601.
-
(2008)
Pediatr. Infect. Dis. J.
, vol.27
, pp. 595-601
-
-
Espie, E.1
Grimont, F.2
Mariani-Kurkdjian, P.3
-
12
-
-
0024400037
-
Hemolytic uremic syndrome and diarrhea in Argentine children: The role of Shiga-like toxins
-
Lopez EL, Diaz M, Grinstein S, et al. Hemolytic uremic syndrome and diarrhea in Argentine children: The role of Shiga-like toxins. J. Infect. Dis. 1989; 160: 469-475.
-
(1989)
J. Infect. Dis.
, vol.160
, pp. 469-475
-
-
Lopez, E.L.1
Diaz, M.2
Grinstein, S.3
-
13
-
-
77952096304
-
Hemolytic uremic syndrome in Switzerland: A nationwide surveillance 1997-2003
-
Swiss Pediatric Surveillance Unit.
-
Schiffelri A, von Vigier RO, Fontana M, et al. Swiss Pediatric Surveillance Unit. Hemolytic uremic syndrome in Switzerland: A nationwide surveillance 1997-2003. Eur. J. Pediatr. 2010; 169: 591-598.
-
(2010)
Eur. J. Pediatr.
, vol.169
, pp. 591-598
-
-
Schiffelri, A.1
Von Vigier, R.O.2
Fontana, M.3
-
14
-
-
0033064066
-
Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli 157:H7 infection: Experience of an outbreak in Sakai City, 1996
-
Yoshioka K, Yagi K, Moriguchi N,. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli 157:H7 infection: Experience of an outbreak in Sakai City, 1996. Pediatr. Int. 1999; 41: 223-227.
-
(1999)
Pediatr. Int.
, vol.41
, pp. 223-227
-
-
Yoshioka, K.1
Yagi, K.2
Moriguchi, N.3
-
15
-
-
0032997531
-
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli 157 infections in Sakai City, 1996
-
Fukushima H, Hashizume T, Morita Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli 157 infections in Sakai City, 1996. Pediatr. Int. 1999; 41: 213-217.
-
(1999)
Pediatr. Int.
, vol.41
, pp. 213-217
-
-
Fukushima, H.1
Hashizume, T.2
Morita, Y.3
-
16
-
-
84865123227
-
Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111
-
Matano S, Inamura K, Konishi M, et al. Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111. J. Infect. Chemother. 2012; 18: 558-564.
-
(2012)
J. Infect. Chemother.
, vol.18
, pp. 558-564
-
-
Matano, S.1
Inamura, K.2
Konishi, M.3
-
17
-
-
84906939751
-
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
-
doi: 10.1007/s10157-013-0856-y
-
Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin. Exp. Nephrol. 2013. doi: 10.1007/s10157-013- 0856-y
-
(2013)
Clin. Exp. Nephrol.
-
-
Uemura, O.1
Nagai, T.2
Ishikura, K.3
-
18
-
-
70350279315
-
Atypical hemolytic-uremic syndrome
-
Noris M, Remuzzi G,. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009; 22: 1676-1687.
-
(2009)
N. Engl. J. Med.
, vol.22
, pp. 1676-1687
-
-
Noris, M.1
Remuzzi, G.2
-
19
-
-
0024148809
-
Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome
-
Robson WL, Fick GH, Wilson PC,. Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome. Child Nephrol. Urol. 1988; 89: 203-207.
-
(1988)
Child Nephrol. Urol.
, vol.89
, pp. 203-207
-
-
Robson, W.L.1
Fick, G.H.2
Wilson, P.C.3
-
20
-
-
0033783260
-
Usefulness of serum fibrinogen product-E in sporadic cases of classical hemolytic uremic syndrome
-
Aihara Y, Nakamura T, Unayama T, Yoshida Y, Yokota S,. Usefulness of serum fibrinogen product-E in sporadic cases of classical hemolytic uremic syndrome. Pediatr. Int. 2000; 42: 523-527.
-
(2000)
Pediatr. Int.
, vol.42
, pp. 523-527
-
-
Aihara, Y.1
Nakamura, T.2
Unayama, T.3
Yoshida, Y.4
Yokota, S.5
-
21
-
-
0018903835
-
CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis
-
Bale JF Jr, Brasher C, Siegler RL,. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am. J. Dis. Child. 1980; 134: 869-872.
-
(1980)
Am. J. Dis. Child.
, vol.134
, pp. 869-872
-
-
Bale, Jr.J.F.1
Brasher, C.2
Siegler, R.L.3
-
22
-
-
0024595998
-
Hyponatraemia and haemolytic uremic syndrome
-
Milford D, Taylor CM,. Hyponatraemia and haemolytic uremic syndrome. Lancet 1989; 25 1(8635): 439.
-
(1989)
Lancet
, vol.25
, Issue.8635
, pp. 439
-
-
Milford, D.1
Taylor, C.M.2
-
23
-
-
10044222206
-
Continuous hemodiafiltration in pediatric critical care patients
-
Shiga H, Hirasawa H, Oda S, Matsuda K, Ueno H, Nakamura M,. Continuous hemodiafiltration in pediatric critical care patients. Ther. Apher. Dial. 2004; 8: 390-397.
-
(2004)
Ther. Apher. Dial.
, vol.8
, pp. 390-397
-
-
Shiga, H.1
Hirasawa, H.2
Oda, S.3
Matsuda, K.4
Ueno, H.5
Nakamura, M.6
-
24
-
-
34248359998
-
Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation
-
Cavagnaro F, Kattan J, Godoy L, et al. Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation. Int. J. Artif. Organs 2007; 30: 220-226.
-
(2007)
Int. J. Artif. Organs
, vol.30
, pp. 220-226
-
-
Cavagnaro, F.1
Kattan, J.2
Godoy, L.3
|